Skip to main content

Table 3 Maximum spinal cord dose and mean mandibular dose (Gray) in the study group and historical control group for oropharyngeal, oral cavity, and laryngeal-hypopharyngeal cancers

From: Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer

Site

Spinal cord

Mandibular

 

Study

Control

p value

Study

Control

p value

Oropharynx

35.2

39.3

0.1

39.2

44.9

0.4

Oral cavity

33.6

36.9

0.1

55.4

57.2

0.4

Larynx and hypopharynx

34.2

36.1

0.5

30

31.8

0.8

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us